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Background: Scrophularia striata Boiss. (Scrophulariaceae) is a plant growing in the northeastern part of Iran and
being used as a traditional herb for various inflammatory disorders.
This study was designed to investigate the protective effects of the Scrophularia striata extract in Ovalbumin (OVA)
induced-asthma mice model.
Methods: OVA-sensitized mice were intrapritonealy treated with two doses (100 and 200 mg/kg) of the extract on
days 8 to 14 separately. Broncoalveolar lavage fluids (BALF) was collected 48 h after the final OVA challenge and
then the number of eosinophils and other inflammatory cells were assessed by direct microscopic counting. In
addition, total immunoglubolin (Ig) E and OVA-specific IgE levels in serum, IL-4 and IL-5 cytokines in BALF were
determined by Enzyme-Linked Immunosorbent Assay. Moreover, phytochemical assay by thin layer
chromatography (TLC) and the 2, 2 diphenyl-1-picrylhydrazyl (DPPH) were used to evaluate the main compounds
and the antioxidant capacity of the plant extract, respectively.
Results: The results showed that the main components; including flavonoids, phenolic compounds and phenyl
propanoids were presented in the S. striata extract. In addition, the treatment with extract significantly reduced the
number of inflammatory cells and suppressed T-helper 2 (Th2) cytokines including IL-4 and IL-5 in BALF. Also, total
IgE and OVA-specific IgE levels in the serum decreased.
Conclusion: Collectively, it is concluded that the extract has the potential to modulate the Th2 cytokines and could
be used as immunomodulatory agent in the treatment of allergic asthma.
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Allergic asthma is a chronic inflammatory disease that
recognized by airway inflammation and obstruction,
mucus hyper secretion and airway hyper responsiveness [1].
The prevalence of inflammatory and allergic airway
diseases such as asthma has significantly increased in re-
cent decades. The asthma is associated to T-helper (Th)
type 2 cells response, immunoglobulin (Ig) E-mediated
mast cell activation, and other inflammatory factors, in-
cluding eosinophils, B cells, cytokines and chemokines [2].
In addition, Th2 lymphocytes play important role in
initiation and progression of allergic diseases such as
asthma through their ability to release interleukin (IL)-4
and IL-5 [3].* Correspondence: rhajiaghaee@yahoo.com
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distribution, and reproduction in any mediumOn the other hand, IL-4 is important to induce of
isotype class switching which is required for B cells to
express IgE and also, IL-5 is pivotal for growth, differen-
tiation, recruitment and survival of eosinophils [4,5].
Therefore, most efforts are being made to reduce the in-
appropriate Th2 response to reduce allergic airway dis-
eases. In this regards, Therapeutic concepts include Th2
cytokine inhibitors; neutralizing antibodies directed IgE,
histamine and leukotriene blockers, as well as other tar-
gets [6,7].
In recent years, many researches have searched to find
novel compounds with greater antioxidant activity. In
this regard, natural compounds isolated from medicinal
plants can be good candidates to study their antioxidant
and anti-inflammatory activities. Scrophularia striata
Boiss. (Scrophulariaceae) is a plant growing in the north-
eastern part of Iran being used as a traditional herb fortral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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been used since ancient times as sedative in folk medicine
and for treatment of illnesses such as scrophulas, scabies,
eczema, psoriasis and tumors [8]. Our previous studies
in vitro demonstrated the inhibitory effect of S. striata
extract on nitric oxide and pro-inflammatory cytokines in-
cluding TNF-α, IL-1β and PGE2 production by macro-
phages [9,10]. In addition, the anti-inflammatory and
immunomodulatory activity of some species of Scrophula-
ria has also been shown by other investigators [11-13].
Moreover, several compounds from various Scrophularia
species with anti-inflammatory and neuroprotective prop-
erties including iridoids and phenyl propanoids have been
isolated [13]. In another study, flavonoids, phenolic com-
pound, quercetin and isorhamnetin 3-O-rutinoside with
antioxidant activity were also isolated from S. striata [14].
Given these data, we decided to evaluate the anti-asthmatic
effect of S. striata extract in Ovalbumin-induced mice
asthma model.
Materials and methods
Plant material and preparation of the extract
The aerial parts of S. striata were collected from Ruin
region in northeastern part of Iran, in May 2010 and air
dried at room temperature. A sample was authenticated
by Dr. Faride Attar, from Tehran University, Faculty of
Sciences and a voucher specimen (Herbarium No: 36501)
was preserved in the herbarium of the Tehran University
Faculty of Sciences, Tehran, Iran. Aerial parts of the plant
was dried, powdered (20 g) and macerated with an 80%
ethanol solution for 3 days with three changes of the solu-
tion. The resulting extract was filtered and evaporated
under vacuum into a dried powder extract of S. striata. In
this study, the extract dissolved in dimethylsulfoxide
(DMSO), (CH3)2SO, (% 0.1 v/v) and then used at appro-
priate concentrations.
Phytochemical assay
In order to recognize chemical components of extract,
thin layer chromatocheraphy (TLC) was used. A variety
of indicators including vanillin sulfuric acid; ferric chlor-
ide and natural product polyethylene glycol were used in
this assay. The indictors were sprayed on prepared thin
layers of extract and were observed at 260 and 280 nm
wavelengths under UV light.
DPPH assay
The DPPH test was used to evaluate the antioxidant
capacity of the plant extract [15]. Briefly, one thousand
microlitres of various concentrations (250, 125, 62.5,
31.25, 15.62 and 7.81 μg/ml) of the extract of S. striata
in ethanol was added to 4 ml of 0.004% methanol solu-
tion of DPPH. After a 60 min incubation period at room
temperature, the absorbance was read against a blank at517 nm. Inhibition of free radical by DPPH in percent
(I %) was calculated in following way:
I% ¼ Ablank–Asampleð Þ=Ablank½ 100
A blank =Absorbance of the control reaction
(containing all reagents except the test compound).
A sample =Absorbance of the test compound. Extract
concentration providing 50% inhibition (IC50%) was calcu-
lated from the graph plotted inhibition percentage against
extract concentration. IC50% values were compared to
IC50% value of a “standard” antioxidant, in this case as-
corbic acid (AA), obtained by the same procedure.
Determination of total phenolic assay
The total phenolic content of dry herbs was determined
by using the Folin-Ciocalteau assay [16]. An aliquot
(1 ml) of extract or standard solution of gallic acid (20,
40, 60, 80 and 100 mg/L) was added to 25 ml volumetric
flask, containing 9 ml of destilled deionised water (dd H2O).
A reagent blank using dd H2O was prepared. One milli-
liter of Folin-Ciocalteu’ sphenol reagent was added to the
mixture and shaken. After 5 min, 10 ml of 7% Na2CO3
solution was added to the mixture. The solution was di-
luted to volume (25 ml) with dd H2O, and mixed. After
incubation for 90 min at room temperature, the absorb-
ance against prepared reagent blank was determined at
750 nm. Data of total phenolic contents are expressed as
milligrams of gallic acid equivalents (GAE) per gram dry
weight (mg GAE/g DW). All samples were analyzed in
duplicates.
Animals
Six- to 7- weeks old male Balb/c mice were purchased
from the Pasteur Institute of Iran (Tehran, Iran). In this
study, all the animal experiments were approved and
performed according to the guidelines of the Ethical
Committee of Institute of Medicinal Plant (IMP). All
mice had access to standard laboratory rodent chow and
water ad libitum. All procedures involving animals were
conducted in accordance with the Guidelines for La-
boratory Animal Experiments in IMP Animal Research
and Care Center.
OVA-sensitization challenge and administration of the
extract
OVA sensitization and airway challenge were performed
as previously described with minor modification [17]. In
brief, mice were sensitization on days 1 and 7 by sub-
cutaneously (SC) injection of 100 μg of ovalbumin
(Sigma, USA) emulsified in 1mg of aluminum hydroxide
(AL (OH) 3) (Merk, USA) as adjuvant in 200 μl of phos-
phate buffered saline (PBS). The efficiency of sensitiza-
tion was assessed by measurement of serum total IgE
Table 1 Phytochemical results of Scrophularia striata
extract
Compounds Reagents Standards Results
Phenylpropanoids and
Terpenoids
Vanillin sulfuric acid Cinamic
acid
+




Table 2 Antioxidant capacity and total phenolics
compounds of S. striata extract
Total Phenolics
compounds in dry





of the extract antioxidant
capacity (mg/g)
10.96 316.69 29.8
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count on day 8. Then, mice were challenged with intra-
peritoneal (IP) injection of 10 μg of ovalbumin in 200 μl
of PBS on day 14. The mice were divided into five
groups, each containing eight mice. The control group
(1) received only PBS (Vehicle). The control group (2)
treated with AL (OH) 3. Positive control group (3) was
immunized by subcutaneous injection of a suspension
containing 100μg of ovalbumin and 1mg AL (OH) 3 in
200 μl of PBS on days 1 and 7. The treatment groups
(4 and 5) were sensitized by ovalbumin and then
intrapritonealy treated with 100 and 200 mg/kg of extract
on days 8 to 14 separately.
Preparation of the bronchoalveolar lavage fluid (BALF)
and inflammatory cells count
Lung lavaging was performed 48 h after the last OVA
challenge (on day 16) for preparation of bronchoalveolar
lavage fluid (BALF). In brief, the thorax cavity of mouse
was opened and then sheerd the omohyiod and stylo-
hyoid muscles, then for prevention of lavage reflux, a
needle or a fine polyethylene tube was fixed in trachea
and 1 ml of PBS was injected to the fixed tube via insu-
lin syrange and then it was aspirated (three time) until 2
ml of BALF was taken. The suspension of BALF was
centrifuged and the supernatant collected and stored at
−70°C. Inflammatory cell numbers including eosinophil,
lymphocyte, neutrophil, macrophage and total cells were
determined by direct microscopic counting with a
hemocytometer after exclusion of dead cells by trypan
blue staining. To determine differential cell counts in
BALF, the cells stained using Diff-Quik Stain reagent
(B4132-1A; Dade Behring Inc., Deerfield, IL) according
to the manufacturer’s instructions.
Evaluation of inflammation score by lung histology study
For evaluation of inflammation score, 48 hours after
OVA-challenge, the lung tissues removed and fixed in
10% neutral buffered formalin at 4°C for 24 h. Tissues
were embedded in paraffin, sectioned at 4 μm thickness,
and then stained with hematoxylin and eosin (H&E) to
estimate inflammation by light microscopy. The degree
of cell inflammation in the lung tissue was scored in a
double-blind screen by two independent investigators [18].
Evaluation of total IgE and OVA-specific IgE levels in
serum
For evaluation of total IgE and OVA-specific IgE levels,
serum samples were collected of the mice on 16 day, re-
spectively. Levels of total mouse IgE and OVA-specific
IgE were determined by enzyme-linked immunosorbent
assay (ELISA) kits (Serotec, Oxford, UK) according to
the manufacturer’s instructions. The absorbance was
measured at 450 nm by a micro plate ELISA reader.Evaluation of Th2 cytokines including IL-4 and IL-5 in
BALF
In order to determine Th2 cytokines, the levels of IL-4,
IL-5 in BALF were measured by enzyme-linked im-
munosorbent assay (ELISA) kits (BioSource International,
Camarillo,CA) according to the manufacturer's protocol.Statistical analysis
Data represented as mean ± standard deviation. Statistical
analyses were performed by one-way analysis of variance
(ANOVA) and a post–hoc Bonferroni’s test to express the
difference among the groups. All analyses performed
using SPSS software16. Data considered statistically sig-
nificant at P < 0.05.Results
Chemical components of extract
Phytochemical assay by thin layer chromatography showed
the main components; including phenyl propanoids, phen-
olic compounds and flavonoids were presented in the S.
striata extract (Table 1).Antioxidant activity and total phenolics compounds
The results of Free radical scavenging capacities of the
extract, measured with DPPH assay, and the ratios
(IC50%) AA/ (IC50%) extract are shown in Table 2. They
represent the ascorbic acid equivalent of the extract anti-
oxidant capacity, i.e. the amount of ascorbic acid in mil-
ligrams equivalent to one gram extract. In addition,
Phenolic compounds have been recognized as antioxi-
dant agents, which act as free radical terminators [19]
and have been known to show medicinal activity as well
as exhibiting physiological functions [20]. The total phe-
nolic compounds of dry herb, respectively as shown in
Table 2 with gallic acid as standards.
Figure 1 Effect of S.striata extract on the recruitment of inflammatory cells in the Broncoalveolar lavage fluid (BALF) of mice. The BALF
samples were collected 48 h after the last Ovalbumin (OVA) challenge. The numbers of eosinophils and total inflammatory cells were assessed by
direct microscopic counting with a hemocytometer. The results showed that the numbers of eosinophils and total inflammatory cells in BALF
were significantly decreased in the S.striata extract treated mice. * P < 0.001 compared with non-treated OVA (Vehicle), # P < 0.001 compared
with OVA-treated group.
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and other inflammatory cells into BALF and lung tissue
The results of cells number were not shown any significant
difference between control groups that received vehicle (1)
comparing with control group (2) that received AL (OH) 3.Figure 2 Effect of S.striata extract on the inflammation score in lung
hematoxylin and eosin and inflammatory cells were studied by light micro
inflammatory cell infiltration in lung sections was performed. Inflammation
challenged groups compared with the control OVA- challenged group. * P
compared with OVA-treated group.As shown in Figure 1, the numbers of the eosinophils and
other inflammatory cells in BALF from the OVA- sensitized
or challenged mice were significantly (P<0.05) higher than
the negative control mice. However, the infiltration of
eosinophils and other inflammatory cells in the BALFtissue. Lung tissue from animals of respective groups was stained with
scopy. Scoring the scope of inflammation by quantitative analysis of
score significantly (P<0.05) reduced in the extract –treated OVA-
< 0.001 compared with non-treated OVA (Control), # P < 0.05
Figure 3 Effect of S.striata extract on the total IgE and OVA-
specific IgE levels in serum. The serum samples were collected
48 h after the last Ovalbumin (OVA) challenge. (A) Total IgE level
(B) OVA-specific IgE level. The results showed that the total IgE and
OVA-specific IgE levels in serum were significantly decreased in the
S.striata extract treated mice. * P < 0.001 compared with non-treated
OVA (Vehicle), # P < 0.001 compared with OVA-treated group.
Figure 4 Effect of S.striata extract on the levels of IL-4 and IL-5
in BALF. In order to determine of Th2 cytokines, the BALF samples
were collected 48 h after the last Ovalbumin (OVA) challenge. IL-4
level (A) and IL-5 level (B). The results showed that IL-4 and IL-5
levels in BALF were significantly decreased in the S. striata extract
treated mice. * P < 0.001 compared with non-treated OVA (Vehicle),
# P < 0.001 compared with OVA-treated group.
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lenged groups compared with the control OVA- challenged
group(P<0.05). Moreover, we determined the suppressive
effect of the extract on the infiltration of inflammatory cells
in the lung tissue. The results indicated that inflammation
score significantly (P<0.05) reduced in the extract –treated
OVA- challenged groups compared with the control OVA-
challenged group (Figure 2).
S. Striata extract decreased total IgE and OVA-specific IgE
in serum
In order to determine the protective effect of S. striata ex-
tract on the IgE and antigen specific IgE production, the total
IgE and OVA-specific IgE levels in serum were evaluated 48h after the last OVA challenge. The results were not shown
any significant difference between the control groups that
received vehicle (1) comparing with control group (2) that
received AL (OH) 3. As shown in Figure 3A and B; OVA-
sensitized or challenged mice showed significantly (P<0.05)
higher levels of IgE (total: 382 ng/ml and specific: 1048 pg/
ml) compared with negative control mice (total: 65 ng/ml).
In addition, treatment with extract significantly decreased
the levels of total IgE and OVA-specific IgE antibodies com-
pared with the control OVA- challenged group (P<0.05).
S. striata extract treatment suppressed the Th2 cytokines
in BALF
To evaluate the effect of S. striata extract on Th2 cyto-
kines in BALF of OVA- sensitized or challenged mice,
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results showed that the levels of IL-4 (94 pg/ml) and
IL-5 (60 pg/ml) cytokines in BALF were significantly
(P<0.05) increased in OVA- sensitized or challenged mice,
while the S. striata extract treatment with 200 mg/kg
significantly (P<0.05) decreased the levels of IL-4 to 56 pg/ml
and IL-5 to 22 pg/ml compared with the control OVA-
challenged group as shown in Figure 4A and B.
Discussion
One of chronic inflammatory disorders is asthma that rec-
ognized by airway infiltration of eosinophils and other in-
flammatory cells, bronchial hyper-responsiveness and
airway obstruction [21,22]. On the other hand, in recent
decades the prevalence of asthma has significantly in-
creased and extensive efforts have been made to recognize
both natural artificial anti-oxidants and anti-asthmatic
agents such as medicinal plants. The anti-oxidant, anti-
inflammatory and immunomodulatory activity of some
species of Scrophularia has also been shown by several in-
vestigators [9,23-25]. In the present study, we investigated
the anti-asthmatic effect of S. striata extract in OVA- sen-
sitized /challenged mice asthma model. S. striata has been
used to treat various inflammatory disorders in animal
models. Our previously studies indicated the inhibitory ef-
fect of S. striata extract on pro-inflammatory mediators
production by macrophages including Nitric Oxide (NO),
TNF-α, IL-1β and PGE2 and also suppressive effect on
matrix metalloproteinases in Wehi-164 tumor cell line
in vitro [9,10,25]. The results of this study showed that the
treatment with S. striata extract (100 and 200 mg/kg) in
OVA- sensitized /challenged mice significantly reduced
the numbers of eosinophils and total inflammatory cells in
the BALF comparing with OVA- sensitized /challenged
mice. Th2 cell, a sub-group of lymphocytes, plays an im-
portant role in the initiation and progression of allergic
asthma by releasing of IL-4 and IL-5 cytokines [26]. More-
over, Th2 response induced airway inflammatory cells in-
filtration, eosinophil activation, IgE production and mucus
secretion [27]. IL-5 cytokine is pivotal for growth, differ-
entiation, recruitment and survival of eosinophils [5]. Our
results indicated that S. striata extract treatment in OVA-
sensitized /challenged mice significantly decreased the
levels of IL-4 and IL-5 cytokines in the BALF comparing
with OVA- sensitized /challenged mice. The decrease of
IL-5 cytokine in the BALF of the mice that had been
treated with both extract and OVA may at least in part be
responsible for the reduced recruitment of eosinophils.
On the other hand, serum IgE level is associated with
bronchial asthma and Th2 response [28]. Moreover, IL-4
cytokine is important to the induction of isotype class
switching which is required for B cells to express IgE [4].
Our finding in this study showed that treatment with ex-
tract significantly decreased total IgE and OVA-specificIgE in the serum of OVA- sensitized /challenged mice that
this effect of the extract may at least in part be responsible
for the decreased IL-4 cytokine production. In addition,
the antioxidant and neuroprotective properties of com-
pounds such as iridoide glycosides and phenylpropanoid
esters isolated from S. buergeriana have been reported
[29-32]. However, in present and previous studies, phen-
olic compounds, phenyl propanoids and two flavonoids,
quercetin and isorhamnetin 3-O-rutinoside, were identi-
fied from S. striata extract [14]. Quercetin is well known
dietary antioxidants and phenolic compounds are also
an anti-inflammatory and antioxidants that the anti-
asthmatic and anti-allergic effects of these compounds
have been previously reported [33-36]. Whether these
compounds are the main responsible compounds for the
anti-asthmatic effects of S. striata or other compounds
are involved in this activity needs further investigation.
In conclusion, the results of this study showed anti-
asthmatic and anti-allergic ability of the S. striata extract
through reducing the IL-4 and IL-5 cytokines production,
total and specific-OVA IgE and also decreasing of eosino-
phils and total inflammatory cells in the BALF of OVA-
sensitized /challenged mice asthma model. Further study
needs for identifying the main anti-allergic bioactive com-
pounds of this plant and other anti-asthmatic mechanisms.
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